Medtronic Stock News

Bank OZK decreased its holdings in shares of Medtronic plc (NYSE:MDT) by 3.4% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 29,006 shares of the medical technology companys stock after selling 1,026 shares during the period. Medtronic comprises approximately []

Legacy Financial Advisors Inc. increased its position in shares of Medtronic plc (NYSE:MDT) by 11.0% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 5,948 shares of the medical technology companys stock after buying an additional 590 shares during the period. Legacy []

Signature Wealth Management Group raised its position in shares of Medtronic plc (NYSE:MDT) by 12.9% in the third quarter, Holdings Channel.com reports. The fund owned 9,490 shares of the medical technology companys stock after buying an additional 1,087 shares during the quarter. Signature Wealth Management Groups holdings in Medtronic were worth $1,190,000 at the end []

Highland Capital Management LLC raised its holdings in Medtronic plc (NYSE:MDT) by 110.5% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 30,506 shares of the medical technology companys stock after purchasing an additional 16,014 shares during the quarter. Highland Capital Management LLCs []

Baxter Bros Inc. bought a new stake in shares of Medtronic plc (NYSE:MDT) during the third quarter, Holdings Channel.com reports. The fund bought 8,224 shares of the medical technology companys stock, valued at approximately $1,031,000. Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. JJJ []

Alpha Cubed Investments LLC purchased a new position in Medtronic plc (NYSE:MDT) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 95,805 shares of the medical technology companys stock, valued at approximately $12,009,000. Several other large investors have also []

Optimum Investment Advisors reduced its stake in Medtronic plc (NYSE:MDT) by 60.4% during the third quarter, Holdings Channel.com reports. The fund owned 950 shares of the medical technology companys stock after selling 1,450 shares during the period. Optimum Investment Advisors holdings in Medtronic were worth $119,000 at the end of the most recent quarter. Several []

Research analysts at Royal Bank of Canada started coverage on shares of Medtronic in a note issued to investors on Thursday, The Fly reports. The firm set an outperform

Research analysts at Royal Bank of Canada started coverage on shares of Medtronic (NYSE:MDT) in a note issued to investors on Thursday, The Fly reports. The firm set an outperform rating and a $140.00 price target on the medical technology companys stock. Royal Bank of Canadas price objective points to a potential upside of 24.52% [] The post Royal Bank of Canada Initiates Coverage on Medtronic (NYSE:MDT) appeared first on ETF Daily News .

Medtronic is moving its Memphis operations to Airways Boulevard. Part of the facility will be sublet to CEVA Logistics, which will create new jobs.

JJJ Advisors Inc. boosted its position in shares of Medtronic plc (NYSE:MDT) by 33.9% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,151 shares of the medical technology companys stock after buying an additional 798 shares during the period. JJJ Advisors []

Blue Fin Capital Inc. reduced its holdings in shares of Medtronic plc (NYSE:MDT) by 14.3% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 2,016 shares of the medical technology companys stock after selling 337 shares during the period. Blue Fin Capital []

Analysts have provided the following ratings for Medtronic (NYSE: MDT ) within the last

Medtronic (NYSE:MDT) announced this week that former pediatric endocrinologist Dr. Jennifer McVean has joined its diabetes business. McVean, a former pediatric endocrinologist for the University of Minnesota Physicians and an associate professor in the pediatrics department at the University of Minnesota Medical School, will take up a role aimed at augmenting Medtronics commitment to providing [] The post Former pediatric endocrinologist joins Medtronics diabetes business as medical affairs director appeared first on Drug Delivery Business .